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INTRODUCTION
Mucin is a macromolecular glycoprotein produced in secre-
tory epithelial cells of the respiratory, gastrointestinal, and the
reproductive tract (1). Mucin is an important component of
airway mucus secretion. Several mucin genes regulate mucin
secretion in human body. Mucus hypersecretion is a major
problem of the inflammatory airway diseases such as chronic
bronchitis, asthma, cystic fibrosis, and chronic rhinosinusitis
(1). Various cytokines and inflammatory mediators stimulate
mucus hypersecretion, directly or indirectly (2, 3). Among
these cytokines and inflammatory mediators, tumor necrosis
factor- (TNF- ) (4, 5), interleukin-1 (IL-1 ) (6), and lipo-
polysaccharide (LPS) (7) activate mucin secretion by up-reg-
ulating expression of the mucin genes (2, 3, 7-9). Thirteen
mucin genes have been identified. Among these mucin genes,
the respiratory mucin genes are MUC2, MUC4, MUC5AC,
MUC5B, MUC6, MUC7, and MUC8 (10-14). The MUC5AC
gene is one of the most important genes in the respiratory
tract. The MUC2 gene is expressed at a low level in a normal
condition, but the expression is increased in chronic bronchitis
and cystic fibrosis (15). 
Among the cytokines that have various inflammatory func-
tions in acute and chronic upper respiratory tract infection, IL-
1 is related with the pathogenesis of respiratory tract infection
in upper airway diseases such as asthma and bronchitis (5, 16,
17). Our recent study (6) demonstrated that IL-1 stimulates
the expression of MUC2 gene and mucin secretion by tran-
scriptional regulation. However, we could not delineate the
specific signal pathway involved in the mediation of mucin
secretion in that study. 
Since it was reported that Pseudomonas aeruginosa-induced
mucin overproduction requires nuclear factor  B (NF- B)
activation in epithelial cells (3), some researchers have stud-
ied to elucidate the signal transduction pathway involved in
the expression of the mucin gene (3, 4, 7, 9, 12). Although a
previous study (18) showed that IL-1 activates mitogen-acti-
vated protein kinase (MAPK) subgroups c-Jun NH2 terminal
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Interleukin-1 Induces MUC2 Gene Expression and Mucin Secretion
via Activation of PKC-MEK/ERK, and PI3K in Human Airway 
Epithelial Cells
Interleukin 1 (IL-1 ), a proinflammatory cytokine, is related with inflammatory dis-
eases and it up-regulates MUC2 gene expression and mucin secretion. This study
was designed to investigate the signal transduction pathway of the IL-1 -mediat-
ed MUC2 gene expression and mucin secretion in human airway epithelial cells.
In cultured human airway NCI-H292 epithelial cells, the steady state of the mRNA
level of MUC2 gene expression and mucin secretion induced by IL-1 were deter-
mined by reverse transcriptase-polymerase chain reaction (RT-PCR), enzyme
immunoassay, and immunoblot analysis. To observe the signal pathway of the
IL-1 -mediated MUC2 gene expression and mucin secretion, we used several
specific inhibitors. PD98059 (MEK/ERK inhibitor) suppressed IL-1 -mediated MUC2
gene expression and mucin secretion, while SB203580 (p38 inhibitor) did not.
Ro31-8220 (PKC inhibitor) inhibited IL-1 -mediated MUC2 gene expression and
mucin secretion. It inhibited ERK phosphorylation, but did not inhibit p38 phosphory-
lation. LY294002 (PI3K inhibitor) also suppressed MUC2 expression, but did not
inhibit any MAPKs phosphorylation. These results suggest that the IL-1 -medi-
ated MUC2 gene expression and mucin secretion in NCI-H292 cells are regulat-
ed through activation of the PKC-MEK/ERK pathway, and that PI3K is also involved
in the IL-1 -mediated MUC2 gene expression and mucin secretion.
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kinase (JNK) and extracellular signal-regulated kinase (ERK)
in human articular chondrocyte, the signal pathway involved
in the IL-1 -mediated MUC2 gene expression and mucin
secretion has not yet been understood clearly.  
The present study was undertaken to investigate the signal
transduction pathway involved in the IL-1 -mediated MUC2
gene expression and mucin secretion. We observed whether
protein kinase C (PKC), MAPKs (ERK, p38 and JNK), and
phosphatidylinositol 3-kinase (PI3K) are involved in the IL-
1 -mediated MUC2 gene expression and mucin secretion in
cultured human airway NCI-H292 epithelial cells.
MATERIALS AND METHODS
Cell Culture
The NCI-H292 airway epithelial cells (human pulmonary
mucoepidermoid carcinoma cell line, American Type Culture
Collection, Rockville, MD) were seeded at a density of 1×106
cells into 6 well plates. Cultures were maintained in the RPMI
1640 medium (Gibco BRL, Grand Island, NY) supplement-
ed with 10% fetal calf serum (Gibco BRL), penicillin (100
U/mL), and streptomycin (100  g/mL) at 37℃ in a humid-
ified atmosphere of 95% air and 5% CO2.When the cultures
were confluent, the cells were incubated with RPMI 1640
medium containing 0.5% fetal calf serum for 24 hr. They were
rinsed with phosphate buffered saline (PBS) and exposed to
human recombinant IL-l (R&D Systems Inc., Minneapolis,
MN) treatment. To study which signal transduction pathway
is related to the MUC2 expression, some cultures were pre-
treated with specific inhibitors such as PD98059 (MEK/ERK
inhibitor, Biomol Research Laboratories, Inc., Plymouth
Meeting, PA), SB203580 (p38 inhibitor, Biomol Research
Laboratories), Ro31-8220 (protein kinase C inhibitor, Biomol
Research Laboratories), and LY294002 (PI3K inhibitor, Biomol
Research Laboratories) at 1 hr before exposed to IL-1 and
then incubated for 8 hr after treatment of IL-1 . Control
cultures remained untreated. Total cellular RNA was extracted
using a Tri-Reagent (Molecular Research Center, Cincinnati,
OH). Cell lysates were prepared in PBS.
IL-1 was dissolved with PBS containing 0.1% bovine
serum albumin, and each specific inhibitor was dissolved in
dimethyl sulfoxide (DMSO) prior to addition to cell cultures.
The final concentrations of DMSO or other vehicle solvents
in the medium were less than 0.1%.
RT-PCR Analysis of the MUC2 Gene 
The method used to detect and quantify the MUC2 mRNA
level employed a modified technique of RT-PCR and has been
described previously in detail (6). Briefly, total RNA was
reverse transcribed into cDNA using random hexanucleotide
primers and MULV reverse transcriptase (Perkin-Elmer, Mor-
risville, NC). The oligonucleotide primers for the PCR part of
the procedure were designed on the basis of the published
sequences of human MUC2 (GenBank Accession No. L21998,
5′primer: TGC CTG GCC CTG TCT TTG: 3′primer:
CAG CTC CAG CAT GAG TGC). The PCR consisted of
35 cycles of denaturation (95℃, 1 min), annealing (60℃,
1 min), and extension (72℃, 1 min) in the presence of 2.5
mM MgC12, and a final extension at 72℃ for 20 min. The
MUC2 DNA fragment generated was 440-bp in size as
expected. The oligonucleotide primers for the  2 microglobu-
lin ( 2M, used as a control gene for the RT-PCR) were pur-
chased from Clontech (Palo Alto, CA) and generated 335-bp
PCR fragment. Specific amplification of MUC2 was con-
firmed by sequencing (dsDNA Cycle Sequencing System,
Gibco BRL). PCR products were separated by electrophoresis
through a 2% agarose gel in 1% Tris-boric acid-EDTA (TBE)
buffer containing 50 ng/mL of ethidium bromide and pho-
tographed using a Polaroid type 55 film. The intensity of the
bands was analyzed with a densitometer.
Immunoassay of the MUC2 Mucin
Cell lysates were prepared in PBS at multiple dilutions, and
50  L of each sample was incubated at 40℃in a 96-well plate
until dry. Plates were then washed three times with PBS,
blocked with 2% bovine serum albumin for 1 hr at room
temperature, washed again three times with PBS, and then
incubated with a MUC2 antibody (Santa Cruz Biotechnology,
Santa Cruz, CA) that has been diluted (1:100) with PBS con-
taining 0.05% Tween-20. After 1 hr, the wells were washed
three times with PBS, and then horseradish peroxidase (HRP)-
conjugated anti-rabbit IgG (Santa Cruz Biotechnology) was
dispensed into each well, and after 4 hr, the plates were washed
three times with PBS. Color was developed with a 3,3′ ,5,5′ -
tetramethylbenzidine peroxidase solution and stopped with
2N-H2SO4. Absorbance was read at 450 nm. The amount of
estimated MUC2 mucin was represented as % above control,
which indicates the excess proportion over control.
Immunoblot Analysis for MAPKs and phospho-MAPKs
For analysis of the MAPKs and their activated form, phos-
pho-MAPKs, the treated cells were washed with cold-PBS,
scraped off, pelleted at 700×g at 4℃, and the cell pellet
was resuspended in lysis buffer (50 mM Tris-HCl, pH 8.0,
5 mM EDTA, 150 nM NaCl, 0.5% Nonidet P-40, 1 mM
phenylmethylsulfonyl fluoride (PMSF), and protease inhibitor
cocktail). The preparation was then clarified by centrifugation,
and the supernatant was saved as a whole-cell lysate. Proteins
(50  g) were separated using 10% reducing SDS-polyacryl-
amide gel and electroblotted in 20% methanol, 25 mM Tris,
and 192 mM glycine onto a nitrocellulose membrane. The
membrane was then blocked with 5% non-fat dry milk in
TTBS (25 mM Tris-HCl, 150 mM NaCl, and 0.2% Tween-20)and then incubated with the indicated antibodies for 4 hr.
ERK, phospho-ERK antibodies and p38, phospho-p38 anti-
bodies were purchased from New England BioLabs (Beverly,
MA). Subsequently, the membrane was washed and incubated
for 1 hr with secondary antibodies conjugated to HRP, rewashed,
and developed using an enhanced chemiluminescence system
(ECL, Amersham Pharmacia Biotech, Inc., Buckinghamshire,
England).
RESULTS
Induction of the MUC2 Gene Expression and Mucin
Secretion by IL-1
When the cultures were confluent, the cultured cells were
incubated with IL-1 in the range of 0.02-20 ng/mL at 37℃
for 8 hr. The total mRNA was extracted and subjected to RT-
PCR analysis. As the dose of IL-1 was increased from 0.02 to
20 ng/mL, there was a parallel increase in the MUC2 mRNA
level. RT-PCR products of  2M mRNA were used as internal
control (Fig. 1A). To define the regulation of mucin secretion
by IL-1 at the protein level, we used immunoassay with a
MUC2 monoclonal antibody. MUC2 mucin secretion was also
increased in a dose-dependent manner, and to a maximal level
at 20 ng/mL of IL-1 (Fig. 1B). These results of mucin secre-
tion were consistent with gene expression data. These data
were similar to those of our previous study (6).
Effect of MAPKs on the IL-1 -mediated MUC2 Gene
Expression and Mucin Secretion 
To examine whether IL-1 activates MAPKs (ERK1/2, p38,
JNK), the phosphorylation level of MAPKs was estimated by
examining their phosphorylation in immunoblot with phos-
pho-specific antibodies. All the three MAPKs phosphorylation
by IL-1 were similar in their extent (Fig. 2). The maximum
levels of phosphorylation induced by IL-1 , as indicated by
immunoblotting, were observed at 20-30 min for three
MAPKs. These results show that IL-1 activates ERK, p38,
and JNK.
We evaluated whether the specific inhibitors of MAPKs
appropriately blocked the phosphorylation of different MAPKs
and which MAPK is involved in the MUC2 gene expression
and mucin secretion induced by IL-1 in NCI-H292 cells.
After the cultured cells were pretreated with PD98059 (50
M) or SB203580 (10  M) for 1 hr, they were stimulated with
IL-1 (20 ng/mL) for 8 hr. PD98059 completely inhibited
IL-1 -stimulated ERK1/2 phosphorylation (Fig. 3A). Also,
pretreatment of PD98059 inhibited the MUC2 gene expression
(Fig. 3B) and mucin secretion (Fig. 3C). SB203580 inhibited
p38 phosphorylation (Fig. 4A), but did not suppress the IL-1 -
mediated MUC2 gene expression (Fig. 4B) or mucin secretion
(Fig. 4C).
Effect of PKC on the IL-1 -mediated MUC2 Gene
Expression and Mucin Secretion
To observe whether PKC activation is related with the signal
pathway of the IL-1 -induced MUC2 gene expression and
mucin secretion, Ro31-8220 (PKC inhibitor) was pretreated.
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Fig. 1. Induction of the IL-1 -mediated MUC2 gene expression
and mucin secretion. (A) The NCI-H292 cells were treated with
various concentrations of IL-1 (0.02, 0.2, 2, 20 ng/mL). The mRNA
levels of MUC2 and  2M were determined by RT-PCR.  2M is
a positive internal control. The amounts of the RT-PCR products of
MUC2 were quantified using densitometry and expressed relative
to the densities of  2M by the ratio of MUC2/ 2M DNA bands.
The data is representative of three independent experiments. (B)
The MUC2 mucin was determined by immunoassay. The data
represent average values of three independent experiments plus
standard deviation.
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Fig. 2. Phosphorylation of three MAPKs (pERK, pp38, pJNK)
according to time of IL-1 treatment. NCI-H292 cells were treat-
ed with 20 ng/mL of IL-1 for 5, 10, 20, 30, 60 min. Analysis of
phosphorylation of each protein was done by immunoblot. ERK2
is a positive internal control. 
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Pretreatment with Ro31-8220 (20  M) for 1 hr inhibited the
IL-1 -mediated MUC2 gene expression and mucin secretion.
To further determine whether PKC acts at upstream or down-
stream molecule of MAPKs, we tested the effect of PKC
inhibitor on the IL-1 -activated MAPKs phosphorylation.
When cells were pretreated with Ro31-8220 (20  M) for 1
hr, only ERK1/2 phosphorylation induced by IL-1 (20 ng/
mL) was attenuated, but p38 and JNK phosphorylation was
not suppressed (Fig. 5B, C).
Effect of PI3K on the IL-1 -mediated MUC2 Gene
Expression and Mucin Secretion
To determine whether PI3K activation is involved in the
IL-1 -induced MUC2 gene expression and mucin secretion,
the cells were pretreated with LY294002 (a PI3K inhibitor)
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Fig. 3. Effects of MEK/ERK inhibitor, PD98059 on the expression
of the IL-1 -mediated ERK phosphorylation (pERK) (A), MUC2
gene expression (B), and mucin secretion (C). Analysis of ERK
phosphorylation was done by immunoblot, MUC2 gene by RT-
PCR, and mucin by immunoassay. ERK2 is a positive internal
control. The amounts of the RT-PCR products of MUC2 gene
were quantified using densitometry and expressed relative to the
density of  2M by the ratio of the MUC2/ 2M DNA bands.  2M
is a positive internal control. The data A and B are acquired from
three independent experiments. The data C represents average
value of three independent experiments and standard deviation.
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Fig. 4. Effects of p38 inhibitor, SB203580 on the expression of the
IL-1 -mediated p38 phosphorylation (pp38) (A), MUC2 gene
expression (B) and mucin secretion (C). Analysis of p38 phos-
phorylation was done by immunoblot, MUC2 gene by RT-PCR
and mucin by immunoassay. ERK2 is a positive internal control.
The amounts of the RT-PCR products of MUC2 gene were quan-
tified using densitometry and expressed relative to the density of
2M by the ratio of the MUC2/ 2M DNA bands.  2M is a posi-
tive internal control. The data A and B are acquired from three
independent experiments. The data C represents average value
of three independent experiments and standard deviation.
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for 1 hr before treatment of IL-1 . In addition, to investigate
its relation with MAPKs, we observed the effect of the PI3K
inhibitor on MAPKs phosphorylation induced by IL-1 . When
the cells were pretreated with the LY294002 (25  M) for 1
hr, LY294002 attenuated the IL-1 -induced MUC2 gene
expression and mucin secretion (Fig. 6B), but did not inhibit
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Fig. 5. Effects of PKC inhibitor, Ro31-8220 on the expression of the
IL-1 -mediated MAPKs phosphorylation (pERK, pp38, pJNK) (A),
MUC2 gene expression (B) and mucin secretion (C). Analysis of
ERK, p38, JNK phosphorylation was done by immunoblot, MUC2
gene by RT-PCR and mucin by immunoassay. ERK2 is a positive
internal control. The amounts of the RT-PCR products of MUC2
gene were quantified using densitometry and expressed relative
to the density of  2M by the ratio of the MUC2/ 2M DNA bands.
2M is a positive internal control. The data A and B are acquired
from three independent experiments. The data C represents
average value of three independent experiments and standard
deviation.
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Fig. 6. Effects of PI3K inhibitor, LY294002 on the expression of
the IL-1 -mediated MAPKs phosphorylations (pERK, pp38,
pJNK) (A), MUC2 gene expression (B), and mucin secretion (C).
Analysis of ERK, p38, and JNK phosphorylation were done by
immunoblot, MUC2 gene by RT-PCR, and mucin by immunoas-
say. ERK2 is a positive internal control. The amounts of the RT-
PCR products of MUC2 gene were quantified using densitometry
and expressed relative to the density of  2M by the ratio of the
MUC2/ 2M DNA bands.  2M is a positive internal positive con-
trol. The data A and B are acquired from three independent
experiments. The data C represents average value of three inde-
pendent experiments and standard deviation.
LY294002
IL-1
Cany MAPKs phosphorylation (Fig. 6A). 
DISCUSSION 
In this study, we observed whether IL-1 could induce
MUC2 gene expression and mucin synthesis through activation
of PKC, MAPKs, or PI3K in cultured human airway NCI-
H292 epithelial cell. Our results show that the MEK/ERK
inhibitor, PD98059, inhibited the IL-1 -mediated MUC2
gene expression and mucin secretion, but a p38 inhibitor,
SB203580, did not. A PKC inhibitor, Ro31-8220, inhibited
the IL-1 -mediated MUC2 gene expression and mucin secre-
tion. Moreover, Ro31-8220 attenuated ERK1/2 phosphory-
lation induced by IL-1 . These results show that PKC and
MEK/ERK are related with the IL-1 -induced MUC2 gene
expression and mucin secretion, and that IL-1 activates PKC
at upstream of ERK. Also, a PI3K inhibitor, LY294002,
attenuated the IL-1 -induced MUC2 gene expression and
mucin secretion, but did not inhibit any MAPKs phospho-
rylation. These findings provide evidence that IL-1 induces
MUC2 gene expression and mucin secretion through activation
of PKC-MEK/ERK-dependent pathway, and through acti-
vation of PI3K.
Since it has been reported that TNF- is related with mucin
secretion in 1995 (4), there were several reports about the
signal pathway of mucin secretion. Li et al. (3) described that
Pseudomonas aeruginosa induced MUC2 gene expression by
NF- B activation via Src-dependent Ras-MAPK-pp90rsk
pathway in epithelial cells. In addition, Basbaum et al. (18)
suggested that the various mucin secretion in epithelial cells
is commonly dependent upon c-Src, MAP kinase kinase
MEK1/2, and NF- B. Recently, Takeyama et al. (19) showed
that the oxidative stress induces mucin synthesis in airway
epithelial cells via epidermal growth factor receptor (EGFR),
which leads to activation of the ERK signal transduction
pathway. However, none of these studies found a direct link
between PKC, ERK, or p38 in the IL-1 -mediated mucin
gene expression and mucin secretion. Although we previously
reported that IL-1 up-regulates MUC2 gene expression and
mucin secretion through transcriptional activation (6), the
specific signal transduction pathways involved in the IL-1 -
mediated mucin gene expression and mucin secretion were
not shown. 
In our experiments, to determine the signal transduction
pathway involved in the IL-1 -mediated MUC2 gene expres-
sion and mucin secretion, we observed the pattern of MUC2
gene expression and mucin secretion using several specific
inhibitors for regulatory molecules in signal transduction. The
IL-1 -induced MUC2 gene expression and mucin secretion
are strongly attenuated by an MEK/ERK inhibitor, PD98059.
We could conclude that MEK/ERK is necessary in the IL-
1 -mediated MUC2 gene expression and mucin secretion.
This result is similar to that Staphylococcus aureus activates the
transcription of the MUC2 gene through the ERK activation
(18) and the transcriptional activation of the MUC2 gene
induced by Pseudomonas aeruginosa requires MAPK (3, 7). 
PKC is related with the MUC2 expression activated by
Pseudomonas aeruginosa (18). The PKC family consists of at
least 12 isoforms that possess distinct differences in struc-
ture, substrate requirment, expression, and localization (20).
To evaluate the effect of PKC in the IL-1 -induced MUC2
expression, we used PKC inhibitor, Ro31-8220. While the
straurosporine analogue Ro31-8220 inhibit PKC , PKC
I, PKC II, PKC , and PKC isoforms (20), it was found to
be an equally potent inhibitor of mitogen- and stress-activated
protein kinase-1(MSK1) activity in vitro (21). MSK1 plays
a role in integrating the effects of different extracellular signals,
and is located in the nucleus of unstimulated or stimulated
cells (21). The substrates of MSK1 are the transcription factor
CREB and ATF1, and MSK1 mediates the activation of CREB
and ATF1 by either growth factors and stress signals (21).
Therefore, there is a possibility that inhibitory effect of Ro31-
8220 on IL-1 -mediated MUC2 expression was through
inhibition of PKC in cytoplasm or inhibition of MSK1 in
nucleus. In this study, the IL-1 -induced MUC2 gene expres-
sion and mucin secretion were inhibited by pretreatment of
a PKC inhibitor (Ro31-8220). This result suggests that PKC
is involved in the signal transduction pathway of the IL-1 -
mediated MUC2 gene expression and mucin secretion. Fur-
thermore, considering the result in which the phosphorylation
of ERK was attenuated by Ro31-8220 at this time, we could
conclude that PKC acts at upstream of ERK. 
PI3K is an important molecule in mitogenic signaling and
cell survival, cytoskeletal remodeling, metabolic control, and
vesicular trafficking (22). And it has been known that PKC
or MAPKs cascades require PI3K activation in several signal
transduction pathway (23-27). In this study, LY294002, an
inhibitor of PI3K, suppressed the IL-1 -induced MUC2 gene
expression and mucin secretion, but not the phosphorylation
of ERK. This result suggests that PI3K also has an important
role in up-regulation of the MUC2 gene expression and mucin
secretion induced by IL-1 . However, PI3K is involved inde-
pendently of PKC-ERK or is located at downstream of MEK
/ERK in the IL-1 -induced MUC2 gene expression and mucin
secretion because LY294002 did not inhibit phosphorylation
of ERK. 
In conclusion, we consider that activation of PKC-ERK
and PI3K is required for the IL-1 -mediated MUC2 gene
expression and mucin secretion in human airway NCI-H292
epithelial cells. However, because specific inhibitors could not
completely inhibit MUC2 gene expression and mucin secretion
induced by IL-1 , other signal pathways must be also involved
in the IL-1 -mediated MUC2 gene expression and mucin
secretion. Furthermore, further studies with various epithelial
cells including normal respiratory epithelium are needed to
clarify the signal transduction pathway involved in the IL-
1 -mediated mucin gene expression and mucin secretion.
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